Viewing Study NCT01332266


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2026-03-08 @ 4:01 AM
Study NCT ID: NCT01332266
Status: COMPLETED
Last Update Posted: 2022-01-03
First Post: 2011-04-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Sponsor: Eisai Inc.
Organization: